Jennifer Sims-Mourtada, et al. “Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT)”. Cancer Studies and Molecular Medicine , vol. 4, no. 1, Jan. 2018, pp. 1-4, https://openventio.us/index.php/CSMM/article/view/1452.